Cathleen M. Brdlik, Ph.D. - Publications
Affiliations: | Yale University, New Haven, CT |
Area:
organic synthesis, pharmacology, molecular biologyYear | Citation | Score | |||
---|---|---|---|---|---|
2008 | Sarup J, Jin P, Turin L, Bai X, Beryt M, Brdlik C, Higaki JN, Jorgensen B, Lau FW, Lindley P, Liu J, Ni I, Rozzelle J, Kumari R, Watson SA, et al. Human epidermal growth factor receptor (HER-1:HER-3) Fc-mediated heterodimer has broad antiproliferative activity in vitro and in human tumor xenografts. Molecular Cancer Therapeutics. 7: 3223-36. PMID 18852126 DOI: 10.1158/1535-7163.Mct-07-2151 | 0.311 | |||
2006 | Yeh JR, Ju R, Brdlik CM, Zhang W, Zhang Y, Matyskiela ME, Shotwell JD, Crews CM. Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrest. Proceedings of the National Academy of Sciences of the United States of America. 103: 10379-84. PMID 16790550 DOI: 10.1073/Pnas.0511313103 | 0.308 | |||
2004 | Brdlik CM, Crews CM. A single amino acid residue defines the difference in ovalicin sensitivity between type I and II methionine aminopeptidases. The Journal of Biological Chemistry. 279: 9475-80. PMID 14676204 DOI: 10.1074/Jbc.M307246200 | 0.308 | |||
Show low-probability matches. |